Retinal vein occlusion (RVO) occurs when a vein carrying blood away from the retina becomes blocked, leading to significant complications such as retinal hemorrhages and edema. This condition typically manifests with sudden, painless vision loss or blurring in one eye, often associated with risk factors like hypertension, diabetes, and cardiovascular diseases. Effective management of RVO involves addressing underlying health issues, such as controlling blood pressure and managing diabetes meticulously. Treatment strategies may include intravitreal injections of anti-VEGF agents or steroids to reduce macular edema. In some cases, laser photocoagulation or surgical interventions are necessary. Regular monitoring is essential to evaluate treatment effectiveness and prevent potential complications like glaucoma or abnormal blood vessel growth in the retina. Early detection and comprehensive management are crucial for optimizing visual outcomes and minimizing long-term damage caused by retinal vein occlusion.
Objective : To investigate the effect of intravitreal implant of ranibizumab combined with dexamethasone on Vascular Endothelial Growth Factors (VEGFs), Interleukins (ILs) and clinical efficacy in…
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Oral and poster slots for original Retinal Vein Occlusion work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Retinal Vein Occlusion research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Retinal Vein Occlusion track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Retinal Vein Occlusion. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Retinal Vein Occlusion are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Retinal Vein Occlusion track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
